BioCryst Pharmaceuticals, Inc

(NASDAQ:BCRX)

Latest On BioCryst Pharmaceuticals, Inc (BCRX):

Date/Time Type Description Signal Details
2023-05-31 17:21 ESTNewsBioCryst Pharmaceuticals: An Updated ViewN/A
2023-05-03 21:24 ESTNewsBioCryst Pharmaceuticals, Inc. 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-03 21:24 ESTNewsBioCryst Pharmaceuticals, Inc. (BCRX) Q1 2023 Earnings Call TranscriptN/A
2023-05-03 21:24 ESTNewsBioCryst gains 14% most since February after Q1 2023 resultsN/A
2023-05-03 08:06 ESTNewsBioCryst Pharmaceuticals GAAP EPS of -$0.28 beats by $0.03, revenue of $68.78M misses by $2.66MN/A
2023-04-18 20:53 ESTNewsBioCryst secures five-year credit facilityN/A
2023-04-12 14:45 ESTNewsThe Big Short: 5 Stocks At Risk With High Short InterestN/A
2023-03-17 06:01 ESTNewsBioCryst's Commercialization Of Orladeyo: Risks Materializing, A Shorting OpportunityN/A
2023-03-08 22:50 ESTNewsBioCryst: Good Candidate For Buyout, But Not For Anything ElseN/A
2023-03-08 22:50 ESTNewsBioCryst wins Canadian nod for Orladeyo reimbursementN/A
2023-03-02 13:37 ESTNewsBioCryst Pharmaceuticals (BCRX) Presents At J.P. MORGAN HEALTHCARE CONFERENCEN/A
2023-02-22 23:25 ESTNewsBioCryst adds 13% to rebound as Needham upgrades; says selloff overdoneN/A
2023-02-22 10:26 ESTNewsBioCryst Is Not Currently Uncovering The Full Value Of ORLADEYON/A
2023-02-21 21:57 ESTNewsBioCryst at nine-month low as Q4 bottom-line disappointsN/A
2023-02-21 21:57 ESTNewsBioCryst Pharmaceuticals, Inc. (BCRX) Q4 2022 Earnings Call TranscriptN/A
2023-02-21 21:57 ESTNewsBioCryst Pharmaceuticals, Inc. 2022 Q4 - Results - Earnings Call PresentationN/A
2023-02-21 08:13 ESTNewsBioCryst Pharmaceuticals Non-GAAP EPS of -$0.38 misses by $0.18, revenue of $79.5M beats by $5.32MN/A
2023-02-20 19:27 ESTNewsBioCryst Pharmaceuticals Q4 2022 Earnings PreviewN/A
2023-02-04 07:22 ESTNewsBioCryst Pharmaceuticals: An Overview Of Orladeyo For Hereditary AngioedemaN/A
2023-01-23 12:51 ESTNewsBioCryst teams up with Swixx to sell Orladeyo in Central, Eastern EuropeN/A
2023-01-09 13:46 ESTNewsBioCryst drops as sales for hereditary angioedema therapy lag forecastsN/A
2022-12-21 02:03 ESTNewsBioCryst Pharmaceuticals: More Aggressive Growth For OrladeyoN/A
2022-12-16 00:24 ESTNewsBioCryst drops on plans to discontinue oral Factor D inhibitorN/A
2022-12-16 00:22 ESTNewsBioCryst strategic interest likely to rise after oral Factor D inhibitor decision - CowenN/A
2022-12-06 15:56 ESTNewsBad flu season turned even worse around Thanksgiving - CDCN/A
2022-11-15 15:48 ESTNewsBioCryst Pharmaceuticals (BCRX) Investor Presentation -SlideshowN/A
2022-11-04 16:23 ESTNewsFewer Americans have received the flu shot compared to same time last year - CDCN/A
2022-11-02 13:59 ESTNewsBioCryst rebounds as Evercore ISI upgrades after earnings day selloffN/A
2022-11-01 22:53 ESTNewsBioCryst Pharmaceuticals reports Q3 earnings beat; updates FY22 guidanceN/A
2022-11-01 22:53 ESTNewsBioCryst Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-01 22:53 ESTNewsBioCryst Pharmaceuticals, Inc. (BCRX) Q3 2022 Earnings Call TranscriptN/A
2022-11-01 22:52 ESTNewsBioCryst falls 11% despite Q3 beat (update)N/A
2022-10-28 13:05 ESTNewsFlu season off to a strong and early start, CDC data findsN/A
2022-10-11 12:49 ESTNewsBioCryst Pharmaceuticals: Working To Increase Market Presence Of OrladeyoN/A
2022-09-14 19:02 ESTNewsBioCryst Pharmaceuticals promotes Sheridan to development chiefN/A
2022-08-31 10:00 ESTNewsBioCryst wins FDA’s Orphan Drug status for bone disorder therapyN/A
2022-08-26 17:59 ESTNewsBioCryst's BCX9930 for rare kidney disorder shows promise in early-stage studyN/A
2022-08-25 09:20 ESTNewsBioCryst to supply 10K doses of influenza drug Rapivab to US for ~$7MN/A
2022-08-18 07:38 ESTNewsBioCryst Orladeyo gets approval in Saudi Arabia to prevent hereditary angioedema attacksN/A
2022-08-04 23:49 ESTNewsBioCryst Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-04 23:49 ESTNewsBioCryst adds 16% as FDA lifts clinical hold on kidney disease programN/A
2022-08-04 23:48 ESTNewsBioCryst Pharmaceuticals, Inc. (BCRX) CEO Jon Stonehouse on Q2 Results - Earnings Call TranscriptN/A
2022-08-04 08:14 ESTNewsBioCryst Pharmaceuticals GAAP EPS of -$0.32 beats by $0.03, revenue of $65.53M beats by $1.7MN/A
2022-08-03 17:46 ESTNewsBioCryst Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-07-26 00:41 ESTNewsBioCryst Pharmaceuticals: Waiting For ClarityN/A
2022-06-24 22:18 ESTNewsBioCryst: A Prudent DiversificationN/A
2022-06-19 14:18 ESTNewsBioCryst Pharmaceuticals (BCRX) Investor Presentation - SlideshowN/A
2022-06-10 13:01 ESTNewsBioCryst collaborates with Pint Pharma to sell Orladeyo in Latin AmericaN/A
2022-06-08 15:55 ESTNewsBioCryst nabs FDA’s Fast Track status for candidate targeting rare bone forming disorderN/A
2022-06-08 00:50 ESTNewsBioCryst Orladeyo gets approval in Switzerland to prevent hereditary angioedema attacksN/A

About BioCryst Pharmaceuticals, Inc (BCRX):

BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor, for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and Mundesine, an oral purine nucleoside phosphorylase inhibitor for peripheral T-cell lymphoma. It is also developing ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema; BCX9930, an oral factor D inhibitor, which is in Phase I clinical trials for mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitors that is in Phase I clinical trials to treat fibrodysplasia ossificans progressiva; and Galidesivir, a RNA dependent-RNA polymerase inhibitor, which is in Phase I clinical trials to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. The company has collaborations and in-license relationships with U.S. Department of Health and Human Services; National Institute of Allergy and Infectious Diseases; Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; Mundipharma International Holdings Limited; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.

BCRX Quotes by TradingView

See Advanced Chart

General

  • Name BioCryst Pharmaceuticals, Inc
  • Symbol BCRX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 246
  • Fiscal Year EndDecember
  • IPO Date1994-03-03
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.biocryst.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 31.41
  • Price/Book (Most Recent Quarter) 56.59
  • Enterprise Value Revenue 103.35
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.05
  • Next Year EPS Estimate -$0.73
  • Next Quarter EPS Estimate -$0.28
  • Operating Margin -981%
  • Return on Assets -43%
  • Return on Equity -1925%
  • Revenue 17.81 million
  • Earnings Per Share -$1.15
  • Revenue Per Share $0.11
  • Gross Profit -106828000
  • Quarterly Earnings Growth -89.9%
View More

Highlights

  • Market Capitalization 2.25 billion
  • EBITDA -106253000
  • PE Ratio -12.32
  • PEG Ratio -0.28
  • Analyst Target Price $13.78
  • Book Value Per Share $0.19
View More

Share Statistics

  • Shares Outstanding 177.52 million
  • Shares Float 162.86 million
  • % Held by Insiders 85%
  • % Held by Institutions 73.95%
  • Shares Short 28.92 million
  • Shares Short Prior Month 28.86 million
  • Short Ratio 3.27
  • Short % of Float 18%
  • Short % of Shares Outstanding 16%
View More

Technicals

  • Beta 2.82
  • 52 Week High $13.93
  • 52 Week Low $1.78
  • 50 Day Moving Average 11.07
  • 200 Day Moving Average 6.8
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

BioCryst Pharmaceuticals, Inc (BCRX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

BioCryst Pharmaceuticals, Inc (BCRX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A-$0.34-$0.24-42.56%
2020-09-302020-11-05$N/A-$0.26-$0.26-1.13%
2020-06-302020-08-06$N/A-$0.24-$0.254.53%
2020-03-312020-05-06$N/A-$0.24-$0.240.62%
2019-12-312020-03-05$39.73 million-$0.02-$0.2792.51%
2019-09-302019-11-06$1.78 million-$0.34-$0.31-8.11%
2019-06-302019-08-06$1.45 million-$0.34-$0.32-7.12%
2019-03-312019-05-08$5.89 million-$0.28-$0.28-1.82%
2018-12-312019-03-04$2.73 million-$0.25-$0.24-2.75%
2018-09-302018-11-06$1.45 million-$0.28-$0.26-7.94%
2018-06-302018-08-07$12.49 million-$0.19-$0.2421.26%
2018-03-312018-05-08$3.98 million-$0.26-$0.19-35.06%
2017-12-312018-02-27$3.89 million-$0.20-$0.16-26.5%
2017-09-302017-11-07$8.76 million-$0.18-$0.182.39%
2017-06-302017-08-07$3.1 million-$0.21-$0.19-10.53%
2017-03-312017-05-04$9.44 million-$0.19-$0.19-2.15%
2016-12-312017-02-27$8.98 million-$0.06-$0.2474.82%
2016-09-302016-11-07$7.76 million-$0.16-$0.2637.84%
2016-06-302016-08-04$4.79 million-$0.22-$0.2615.25%
2016-03-312016-05-05$4.82 million-$0.31-$0.23-34.32%
2015-12-312016-02-23$4.6 million-$0.25-$0.250.68%
2015-09-302015-11-05$10.99 million-$0.20-$0.200%
2015-06-302015-08-07$25.84 million$0.06-$0.22127.27%
2015-03-312015-05-08$6.83 million-$0.21-$0.2516%
2014-12-312015-02-18$5.45 million-$0.16-$0.2123.81%
2014-09-302014-11-06$3.24 million-$0.12-$0.2040%
2014-06-302014-08-05$1.47 million-$0.23-$0.19-21.05%
2014-03-312014-05-08$3.46 million-$0.17-$0.170%
2013-12-312014-02-26$10.57 million-$0.09-$0.090%
2013-09-302013-11-05$2.39 million-$0.14-$0.11-27.27%
2013-06-302013-08-08$821000-$0.23-$0.13-76.92%
2013-03-312013-05-07$3.55 million-$0.09-$0.1540%
2012-12-312013-02-19$4.1 million-$0.18-$0.16-12.5%
2012-09-302012-11-08$5.76 million-$0.19-$0.2524%
2012-06-302012-08-02$4.21 million-$0.25-$0.263.85%
2012-03-312012-05-07$12.22 million-$0.13-$0.2650%
2011-12-312012-02-16$5.22 million-$0.29-$0.28-3.57%
2011-09-302011-11-02$5.25 million-$0.32-$0.26-23.08%
2011-06-302011-08-04$3.74 million-$0.36-$0.25-44%
2011-03-312011-05-04$5.44 million-$0.29-$0.20-45%
2010-12-312011-02-10$16.69 million-$0.20-$0.214.76%
2010-09-302010-10-28$12 million-$0.24-$0.17-41.18%
2010-06-302010-08-05$7.62 million-$0.23-$0.22-4.55%
2010-03-312010-04-28$26.07 million-$0.06-$0.1662.5%
2009-12-312010-02-04$54.9 million$0.35$0.09288.89%
2009-09-302009-10-29$10.55 million-$0.28-$0.22-27.27%
2009-06-302009-07-30$4.79 million-$0.23-$0.258%
2009-03-312009-05-08$4.36 million-$0.24-$0.2814.29%
2008-12-312009-02-06$34.24 million$0.26-$0.22218.18%
2008-09-302008-10-31$8.89 million-$0.24-$0.240%
2008-06-302008-08-07$2.66 million-$0.33-$0.20-65%
2008-03-312008-05-08$10.77 million-$0.34-$0.18-88.89%
2007-12-312008-03-04$28.17 million-$0.06-$0.3984.62%
2007-09-302007-11-08$20.46 million-$0.32-$0.28-14.29%
2007-06-302007-08-09$13.44 million-$0.24-$0.3327.27%
2007-03-312007-05-09$9.16 million-$0.30-$0.27-11.11%
2006-12-312007-02-07$2.09 million-$0.34-$0.5032%
2006-09-302006-11-08$1.79 million-$0.53-$0.41-29.27%
2006-06-302006-08-09$1.56 million-$0.35-$0.29-20.69%
2006-03-312006-04-27$771000-$0.27-$0.24-12.5%
2005-12-312006-02-08$21000-$0.27-$0.296.9%
2005-09-302005-10-26$32000-$0.29-$0.24-20.83%
2005-06-302005-08-03$58000-$0.22-$0.2512%
2005-03-312005-04-21$41000-$0.24-$0.240%
2004-12-312005-02-02$178000-$0.24-$0.267.69%
2004-09-302004-10-20$116000-$0.24-$0.240%
2004-06-302004-07-21$43000-$0.23-$0.2817.86%
2004-03-312004-04-21$N/A-$0.28-$0.22-27.27%
2003-12-312004-02-04$654000-$0.18-$0.2010%
2003-09-302003-10-20$N/A-$0.19
2003-06-302003-07-30$N/A-$0.18
2003-03-312003-03-31$N/A-$0.16
2002-12-312002-12-31$N/A-$0.16
2002-09-302002-09-30$N/A-$0.19
2002-06-302002-06-30$N/A-$0.29
2002-03-312002-03-31$N/A-$0.32
2001-12-312002-01-30$4.34 million-$0.28-$0.14-100%
2001-09-302001-10-24$3.4 million$0.02-$0.13115.38%
2001-06-302001-07-25$3.64 million-$0.08-$0.1233.33%
2001-03-312001-04-25$703000-$0.08-$0.1127.27%
2000-12-312001-02-01$803000-$0.11-$0.128.33%
2000-09-302000-10-25$763000-$0.09-$0.1118.18%
2000-06-302000-07-26$1.19 million-$0.11-$0.128.33%
2000-03-312000-04-26$564000$0.10-$0.04350%
1999-12-312000-02-02-$0.03-$0.01-200%
1999-09-301999-10-21-$0.15-$0.1816.67%
1999-06-301999-07-21-$0.02-$0.0875%
1999-03-311999-03-31-$0.16
1998-12-311999-01-27-$0.10-$0.2458.33%
1998-09-301998-10-28$0.19$0.185.56%
1998-06-301998-07-22-$0.21-$0.2516%
1998-03-311998-03-31-$0.22
1997-12-311998-02-03-$0.21-$0.238.7%
1997-03-311997-04-28-$0.23-$0.12-91.67%
1996-12-311997-02-10-$0.15-$0.2128.57%
1996-09-301996-10-29-$0.23-$0.2817.86%
1996-06-301996-07-25-$0.11$0.05-320%
1996-03-311996-04-24-$0.20-$0.2623.08%
1995-12-311996-01-29-$0.23-$0.2611.54%
1995-09-301995-10-17-$0.20-$0.2313.04%
1995-06-301995-07-25-$0.18-$0.3345.45%
1995-03-311995-04-28-$0.37-$0.31-19.35%
1994-12-311995-01-31-$0.24-$0.267.69%
1994-09-301994-10-26-$0.22-$0.3129.03%
1994-06-301994-08-02-$0.25-$0.3324.24%

BioCryst Pharmaceuticals, Inc (BCRX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

BioCryst Pharmaceuticals, Inc (BCRX) Chart:

BCRX chart by TradingView

BioCryst Pharmaceuticals, Inc (BCRX) News:

Below you will find a list of latest news for BioCryst Pharmaceuticals, Inc (BCRX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

BioCryst Pharmaceuticals, Inc (BCRX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-08-1520CALL0 0768.51TRUE00
2025-08-1530CALL0 0557.9TRUE00
2025-08-1540CALL0 00TRUE00
2025-08-1550CALL0 0497.01TRUE00
2025-08-1560CALL0 0278.64TRUE00
2025-08-1571.25CALL0 57196.67TRUE00
2025-08-1580.41CALL0 221984.79TRUE00
2025-08-1590.05CALL1 75780.63FALSE00
2025-08-15100.02CALL0 1424117.22FALSE00
2025-08-15110.05CALL1 175183.39FALSE0.050
2025-08-15120.05CALL0 343195.62FALSE00
2025-08-15130CALL0 0434.08FALSE00
2025-08-15140CALL0 0474.39FALSE00
2025-08-15150CALL0 0317.39FALSE00
2025-08-15160CALL0 0543.41FALSE00
2025-08-15170CALL0 0573.46FALSE00
2025-08-15180CALL0 0601.15FALSE00
2025-08-1520PUT0 01307.68FALSE00
2025-08-1530PUT0 0953.04FALSE00
2025-08-1540PUT0 0719.32FALSE00
2025-08-1550PUT0 0542.45FALSE00
2025-08-1560.1PUT0 1396.63FALSE00
2025-08-1570.01PUT0 163102.51FALSE00
2025-08-1580.14PUT25 238667.25FALSE0.040.4
2025-08-1590.6PUT0 28868.28TRUE00
2025-08-15101.86PUT1 308146.08TRUE1.860
2025-08-15112.9PUT0 10245.86TRUE00
2025-08-15120PUT0 0317.17TRUE00
2025-08-15130PUT0 0359.25TRUE00
2025-08-15140PUT0 0396.66TRUE00
2025-08-15150PUT0 0430.36TRUE00
2025-08-15160PUT0 0461.04TRUE00
2025-08-15170PUT0 00TRUE00
2025-08-15180PUT0 0615.18TRUE00
2025-09-1910CALL0 0363.57TRUE00
2025-09-1925.5CALL0 27238.15TRUE00
2025-09-1935.9CALL0 8279.25TRUE00
2025-09-1945.85CALL0 1209.16TRUE00
2025-09-1950CALL0 0121.9TRUE00
2025-09-1962.55CALL0 72120.01TRUE00
2025-09-1971.25CALL4 5930.68TRUE1.250
2025-09-1980.57CALL16 366741.86TRUE-0.13-0.19
2025-09-1990.19CALL14 67546.37FALSE0.190
2025-09-19100.07CALL275 129147.27FALSE-0.03-0.3
2025-09-19110.01CALL25 86043.19FALSE-0.09-0.9
2025-09-19120.1CALL0 65870.8FALSE00
2025-09-19130.1CALL0 41472.4FALSE00
2025-09-19140.15CALL0 65151.19FALSE00
2025-09-19150CALL0 19162.8FALSE00
2025-09-19160CALL0 10117.81FALSE00
2025-09-19170CALL0 0182.98FALSE00
2025-09-19180CALL0 0191.86FALSE00
2025-09-19190CALL0 0200.09FALSE00
2025-09-19200CALL0 0207.76FALSE00
2025-09-19210CALL0 0214.94FALSE00
2025-09-1910PUT0 0659.98FALSE00
2025-09-1920PUT0 0419.95FALSE00
2025-09-1930PUT0 0306.26FALSE00
2025-09-1940PUT0 0231.37FALSE00
2025-09-1950PUT0 0174.72FALSE00
2025-09-1960PUT0 10128.04FALSE00
2025-09-1970.25PUT0 10649.37FALSE00
2025-09-1980.15PUT0 6145.84FALSE00
2025-09-1991PUT25 3447.54TRUE10
2025-09-19101.88PUT15 8754.65TRUE1.880
2025-09-19112.2PUT0 9175.18TRUE00
2025-09-19120PUT0 090.1TRUE00
2025-09-19132.37PUT0 0120.42TRUE00
2025-09-19140PUT0 0133.02TRUE00
2025-09-19150PUT0 2135.66TRUE00
2025-09-19160PUT0 0145.79TRUE00
2025-09-19170PUT0 0180.29TRUE00
2025-09-19180PUT0 0139.04TRUE00
2025-09-19190PUT0 0171.88TRUE00
2025-09-19200PUT0 0153.65TRUE00
2025-09-19210PUT0 0196.46TRUE00
2025-12-1910CALL0 0692.21TRUE00
2025-12-1929.2CALL0 5317.08TRUE00
2025-12-1930CALL0 0101.34TRUE00
2025-12-1940CALL0 0136.14TRUE00
2025-12-1954.44CALL0 2102.09TRUE00
2025-12-1960CALL0 042.79TRUE00
2025-12-1971.65CALL0 1648.71TRUE00
2025-12-1981.3CALL0 6942.11TRUE00
2025-12-1990.95CALL3 12945.38FALSE0.250.36
2025-12-19100.39CALL1 6447.13FALSE0.390
2025-12-19110.15CALL1 22541.33FALSE-0.15-0.5
2025-12-19120.38CALL3 5066.95FALSE0.380
2025-12-19130.15CALL0 156.6FALSE00
2025-12-19140.35CALL0 6581.81FALSE00
2025-12-19150.1CALL0 12288.21FALSE00
2025-12-19160CALL0 094FALSE00
2025-12-19170CALL0 099.31FALSE00
2025-12-19180.36CALL0 2104.19FALSE00
2025-12-19190.01CALL0 3108.72FALSE00
2025-12-19200.05CALL0 1112.93FALSE00
2025-12-19210CALL0 0116.88FALSE00
2025-12-1910PUT0 0363.61FALSE00
2025-12-1920PUT0 0231.56FALSE00
2025-12-1930PUT0 0169.14FALSE00
2025-12-1940PUT0 0128.07FALSE00
2025-12-1950PUT0 091.86FALSE00
2025-12-1960.05PUT0 162.92FALSE00
2025-12-1970PUT0 050.57FALSE00
2025-12-1980.75PUT3 346.8FALSE0.750
2025-12-1991.45PUT0 6817.16TRUE00
2025-12-19102.09PUT6 1148.24TRUE2.090
2025-12-19111.85PUT0 1143.74TRUE00
2025-12-19120PUT0 054.96TRUE00
2025-12-19130PUT0 057.18TRUE00
2025-12-19140PUT0 074.78TRUE00
2025-12-19150PUT0 076.41TRUE00
2025-12-19160PUT0 0100.08TRUE00
2025-12-19170PUT0 081.28TRUE00
2025-12-19180PUT0 0111.44TRUE00
2025-12-19190PUT0 0116.55TRUE00
2025-12-19200PUT0 0107.89TRUE00
2025-12-19210PUT0 00TRUE00
2026-01-1610CALL0 2170.18TRUE00
2026-01-1620CALL0 50307.08TRUE00
2026-01-1630CALL0 14164.03TRUE00
2026-01-1640CALL0 10273.76TRUE00
2026-01-1653.7CALL0 133259.28TRUE00
2026-01-1663CALL0 20662.71TRUE00
2026-01-1672.08CALL0 109149.31TRUE00
2026-01-1681.47CALL0 219119.16TRUE00
2026-01-1690.8CALL1 41848.88FALSE0.80
2026-01-16100.41CALL73 684643.43FALSE0.410
2026-01-16110.35CALL0 47644.15FALSE00
2026-01-16120.17CALL6 140746.25FALSE-0.09-0.35
2026-01-16130.25CALL0 12055.29FALSE00
2026-01-16140.15CALL0 10563.28FALSE00
2026-01-16150.09CALL0 53159.41FALSE00
2026-01-16160.05CALL0 2861.03FALSE00
2026-01-16170.31CALL0 189.82FALSE00
2026-01-16180.3CALL0 194.26FALSE00
2026-01-16190.05CALL0 398.37FALSE00
2026-01-16200.1CALL0 5102.19FALSE00
2026-01-16210.05CALL0 13105.78FALSE00
2026-01-1610PUT0 0330.42FALSE00
2026-01-1620.01PUT0 6109.88FALSE00
2026-01-1630PUT0 1480.07FALSE00
2026-01-1640PUT0 0116.54FALSE00
2026-01-1650.07PUT0 26661.61FALSE00
2026-01-1660.15PUT0 757.42FALSE00
2026-01-1670PUT0 469546.28FALSE00
2026-01-1680PUT0 135.7FALSE00
2026-01-1691.1PUT0 2443.9TRUE00
2026-01-16101.93PUT0 22057.99TRUE00
2026-01-16112.4PUT0 5261.46TRUE00
2026-01-16123.55PUT0 10058.63TRUE00
2026-01-16130PUT0 053.45TRUE00
2026-01-16140PUT0 092.09TRUE00
2026-01-16154.7PUT0 086.54TRUE00
2026-01-16160PUT0 092.45TRUE00
2026-01-16170PUT0 0110.63TRUE00
2026-01-16180PUT0 0115.86TRUE00
2026-01-16190PUT0 0107.72TRUE00
2026-01-16200PUT0 0112.17TRUE00
2026-01-16210PUT0 0116.35TRUE00
2026-03-2010CALL0 0138.97TRUE00
2026-03-2026.8CALL0 20250.26TRUE00
2026-03-2030CALL0 0148.99TRUE00
2026-03-2044.7CALL0 7111.19TRUE00
2026-03-2053.8CALL0 3046.42TRUE00
2026-03-2060CALL0 037.78TRUE00
2026-03-2070CALL0 046.54TRUE00
2026-03-2081.6CALL0 20327.53TRUE00
2026-03-2091.15CALL0 8330.66FALSE00
2026-03-20100.63CALL13 2045.44FALSE0.630
2026-03-20110.47CALL0 344.32FALSE00
2026-03-20120.33CALL0 1051.58FALSE00
2026-03-20130CALL0 052.43FALSE00
2026-03-20140CALL0 053.07FALSE00
2026-03-20150CALL0 057.69FALSE00
2026-03-20160CALL0 071.44FALSE00
2026-03-20170CALL0 075.52FALSE00
2026-03-2010PUT0 0280.37FALSE00
2026-03-2020PUT0 0178.69FALSE00
2026-03-2030PUT0 0130.71FALSE00
2026-03-2040PUT0 099.16FALSE00
2026-03-2050PUT0 071.35FALSE00
2026-03-2060PUT0 060.46FALSE00
2026-03-2070PUT0 046.08FALSE00
2026-03-2080PUT0 046.42FALSE00
2026-03-2090PUT0 040.2TRUE00
2026-03-20101.9PUT0 63154.49TRUE00
2026-03-20110PUT0 052.41TRUE00
2026-03-20120PUT0 066.3TRUE00
2026-03-20130PUT0 068.77TRUE00
2026-03-20140PUT0 053.07TRUE00
2026-03-20150PUT0 066.43TRUE00
2026-03-20160PUT0 062.84TRUE00
2026-03-20170PUT0 091.01TRUE00
2027-01-1539CALL0 6196.47TRUE00
2027-01-1554.9CALL0 34575.23TRUE00
2027-01-1572.88CALL0 23653.5TRUE00
2027-01-15101.5CALL0 43750.53FALSE00
2027-01-15121.1CALL0 27044.89FALSE00
2027-01-15150.68CALL0 16547.26FALSE00
2027-01-15170.4CALL1 10744.8FALSE-0.11-0.22
2027-01-15200.2CALL0 3059.41FALSE00
2027-01-1530PUT0 12291.27FALSE00
2027-01-1550PUT0 367.72FALSE00
2027-01-1570.9PUT0 12552FALSE00
2027-01-15102.7PUT100 15845.84TRUE2.70
2027-01-15122.5PUT0 1746.53TRUE00
2027-01-15150PUT0 144.62TRUE00
2027-01-15170PUT0 078.57TRUE00
2027-01-15200PUT0 091.08TRUE00

Latest BCRX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST62$9.355
Jun 13, 2022 7:59 PM EST55$9.355
Jun 13, 2022 7:59 PM EST25$9.355
Jun 13, 2022 7:59 PM EST10$9.355
Jun 13, 2022 7:59 PM EST1$9.355

BioCryst Pharmaceuticals, Inc (BCRX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000110465920072065/0001104659-20-072065-index.htm
2020-04-27UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/882796/000000000020003589/0000000000-20-003589-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000021545719003209/0000215457-19-003209-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000083423720004615/0000834237-20-004615-index.htm
2019-11-19SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000089914019000618/0000899140-19-000618-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000089914020000183/0000899140-20-000183-index.htm
2020-04-17SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000090266420001843/0000902664-20-001843-index.htm
2019-01-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000093041319000073/0000930413-19-000073-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000093247119004892/0000932471-19-004892-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000110465919008702/0001104659-19-008702-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000110465920018856/0001104659-20-018856-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000110465920021757/0001104659-20-021757-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000110465920021905/0001104659-20-021905-index.htm
2020-06-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000110465920072065/0001104659-20-072065-index.htm
2018-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218036067/0001127602-18-036067-index.htm
2018-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218036977/0001127602-18-036977-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218037163/0001127602-18-037163-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218037166/0001127602-18-037166-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218037170/0001127602-18-037170-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218037173/0001127602-18-037173-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218037177/0001127602-18-037177-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760218037182/0001127602-18-037182-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219000701/0001127602-19-000701-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219000710/0001127602-19-000710-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219000720/0001127602-19-000720-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219000730/0001127602-19-000730-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219000736/0001127602-19-000736-index.htm
2019-01-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219001579/0001127602-19-001579-index.htm
2019-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219001582/0001127602-19-001582-index.htm
2019-01-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219002141/0001127602-19-002141-index.htm
2019-01-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219002367/0001127602-19-002367-index.htm
2019-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219002527/0001127602-19-002527-index.htm
2019-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219003053/0001127602-19-003053-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219003737/0001127602-19-003737-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219011361/0001127602-19-011361-index.htm
2019-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219014988/0001127602-19-014988-index.htm
2019-05-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219017457/0001127602-19-017457-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219018347/0001127602-19-018347-index.htm
2019-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219018740/0001127602-19-018740-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219019143/0001127602-19-019143-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219019891/0001127602-19-019891-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219020298/0001127602-19-020298-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219020302/0001127602-19-020302-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219020306/0001127602-19-020306-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219020310/0001127602-19-020310-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219020312/0001127602-19-020312-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219020314/0001127602-19-020314-index.htm
2019-07-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219023817/0001127602-19-023817-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219023901/0001127602-19-023901-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219027858/0001127602-19-027858-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219027862/0001127602-19-027862-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219027867/0001127602-19-027867-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219027871/0001127602-19-027871-index.htm
2019-09-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219029010/0001127602-19-029010-index.htm
2019-09-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219029012/0001127602-19-029012-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033001/0001127602-19-033001-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033004/0001127602-19-033004-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033008/0001127602-19-033008-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033017/0001127602-19-033017-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033022/0001127602-19-033022-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033025/0001127602-19-033025-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033029/0001127602-19-033029-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033033/0001127602-19-033033-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219033035/0001127602-19-033035-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219034162/0001127602-19-034162-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219034165/0001127602-19-034165-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219034168/0001127602-19-034168-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219034170/0001127602-19-034170-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035542/0001127602-19-035542-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035544/0001127602-19-035544-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035547/0001127602-19-035547-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035549/0001127602-19-035549-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035551/0001127602-19-035551-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035553/0001127602-19-035553-index.htm
2019-12-264/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035849/0001127602-19-035849-index.htm
2019-12-264/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760219035852/0001127602-19-035852-index.htm
2020-01-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220001879/0001127602-20-001879-index.htm
2020-01-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220001981/0001127602-20-001981-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220006477/0001127602-20-006477-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220006488/0001127602-20-006488-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220006497/0001127602-20-006497-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220006501/0001127602-20-006501-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220006505/0001127602-20-006505-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220006508/0001127602-20-006508-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220007615/0001127602-20-007615-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220007625/0001127602-20-007625-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220007640/0001127602-20-007640-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220007672/0001127602-20-007672-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220007677/0001127602-20-007677-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220007687/0001127602-20-007687-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220009058/0001127602-20-009058-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220009065/0001127602-20-009065-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220009089/0001127602-20-009089-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220009094/0001127602-20-009094-index.htm
2020-03-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220009104/0001127602-20-009104-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220009112/0001127602-20-009112-index.htm
2020-04-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220013457/0001127602-20-013457-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220015179/0001127602-20-015179-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016548/0001127602-20-016548-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016559/0001127602-20-016559-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016565/0001127602-20-016565-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016569/0001127602-20-016569-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016571/0001127602-20-016571-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016575/0001127602-20-016575-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016580/0001127602-20-016580-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016584/0001127602-20-016584-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220016759/0001127602-20-016759-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220018704/0001127602-20-018704-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220018711/0001127602-20-018711-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220018715/0001127602-20-018715-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220018719/0001127602-20-018719-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220023449/0001127602-20-023449-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220024637/0001127602-20-024637-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220024642/0001127602-20-024642-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220024644/0001127602-20-024644-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/882796/000112760220024646/0001127602-20-024646-index.htm
2019-11-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/882796/000114036119020338/0001140361-19-020338-index.htm
2019-11-14424B2Prospectus [Rule 424(b)(2)]https://www.sec.gov/Archives/edgar/data/882796/000114036119020642/0001140361-19-020642-index.htm
2019-11-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000114036119020752/0001140361-19-020752-index.htm
2019-11-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000114036119020989/0001140361-19-020989-index.htm
2019-11-21424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/882796/000114036119021082/0001140361-19-021082-index.htm
2019-11-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000114036119021088/0001140361-19-021088-index.htm
2020-04-24S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/882796/000114036120009639/0001140361-20-009639-index.htm
2020-05-04CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/882796/000114036120010641/0001140361-20-010641-index.htm
2020-05-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/882796/000114036120011394/0001140361-20-011394-index.htm
2020-05-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/882796/000114036120012557/0001140361-20-012557-index.htm
2020-05-29424B2Prospectus [Rule 424(b)(2)]https://www.sec.gov/Archives/edgar/data/882796/000114036120012652/0001140361-20-012652-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000114036120012787/0001140361-20-012787-index.htm
2020-06-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/882796/000114036120013520/0001140361-20-013520-index.htm
2020-06-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/882796/000114036120013521/0001140361-20-013521-index.htm
2020-06-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/882796/000114036120013522/0001140361-20-013522-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000114420419007217/0001144204-19-007217-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000114420419008282/0001144204-19-008282-index.htm
2019-01-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319000006/0001171843-19-000006-index.htm
2019-01-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319000126/0001171843-19-000126-index.htm
2019-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319000749/0001171843-19-000749-index.htm
2019-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319001171/0001171843-19-001171-index.htm
2019-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319001442/0001171843-19-001442-index.htm
2019-03-1410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/882796/000117184319001727/0001171843-19-001727-index.htm
2019-04-17DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/882796/000117184319002458/0001171843-19-002458-index.htm
2019-04-17DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/882796/000117184319002459/0001171843-19-002459-index.htm
2019-04-29S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/882796/000117184319002720/0001171843-19-002720-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319003094/0001171843-19-003094-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/882796/000117184319003220/0001171843-19-003220-index.htm
2019-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319003529/0001171843-19-003529-index.htm
2019-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319003812/0001171843-19-003812-index.htm
2019-06-04S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/882796/000117184319003816/0001171843-19-003816-index.htm
2019-06-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319004220/0001171843-19-004220-index.htm
2019-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319004257/0001171843-19-004257-index.htm
2019-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319004259/0001171843-19-004259-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319005182/0001171843-19-005182-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/882796/000117184319005326/0001171843-19-005326-index.htm
2019-09-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319005941/0001171843-19-005941-index.htm
2019-09-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319006063/0001171843-19-006063-index.htm
2019-09-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319006137/0001171843-19-006137-index.htm
2019-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319006859/0001171843-19-006859-index.htm
2019-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319007064/0001171843-19-007064-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319007155/0001171843-19-007155-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319007214/0001171843-19-007214-index.htm
2019-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319007363/0001171843-19-007363-index.htm
2019-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/882796/000117184319007384/0001171843-19-007384-index.htm
2019-12-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184319008053/0001171843-19-008053-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320000183/0001171843-20-000183-index.htm
2020-01-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320000241/0001171843-20-000241-index.htm
2020-02-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320000650/0001171843-20-000650-index.htm
2020-02-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320001018/0001171843-20-001018-index.htm
2020-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320001229/0001171843-20-001229-index.htm
2020-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320001491/0001171843-20-001491-index.htm
2020-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320001492/0001171843-20-001492-index.htm
2020-03-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320001589/0001171843-20-001589-index.htm
2020-03-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/882796/000117184320001710/0001171843-20-001710-index.htm
2020-03-19PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/882796/000117184320001853/0001171843-20-001853-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320002124/0001171843-20-002124-index.htm
2020-03-31DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/882796/000117184320002184/0001171843-20-002184-index.htm
2020-03-31DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/882796/000117184320002185/0001171843-20-002185-index.htm
2020-04-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320002295/0001171843-20-002295-index.htm
2020-04-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320002530/0001171843-20-002530-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320003357/0001171843-20-003357-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/882796/000117184320003557/0001171843-20-003557-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320003680/0001171843-20-003680-index.htm
2020-08-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320005453/0001171843-20-005453-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320005596/0001171843-20-005596-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/882796/000117184320005753/0001171843-20-005753-index.htm
2020-08-12S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/882796/000117184320005862/0001171843-20-005862-index.htm
2020-08-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320006161/0001171843-20-006161-index.htm
2020-08-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320006178/0001171843-20-006178-index.htm
2020-09-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320006249/0001171843-20-006249-index.htm
2020-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320006729/0001171843-20-006729-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/882796/000117184320007628/0001171843-20-007628-index.htm
2020-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/882796/000117184320007740/0001171843-20-007740-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000117266120000839/0001172661-20-000839-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000119380519000192/0001193805-19-000192-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000119380520000190/0001193805-20-000190-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000127417319000036/0001274173-19-000036-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000127417320000008/0001274173-20-000008-index.htm
2019-05-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000131924419000051/0001319244-19-000051-index.htm
2020-01-22SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/882796/000131924420000014/0001319244-20-000014-index.htm
2020-05-14EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/882796/999999999520001159/9999999995-20-001159-index.htm
2018-12-17CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/882796/999999999718009595/9999999997-18-009595-index.htm
2020-05-01CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/882796/999999999720002395/9999999997-20-002395-index.htm

BioCryst Pharmaceuticals, Inc (BCRX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of BioCryst Pharmaceuticals, Inc (BCRX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 85%
Institutional Ownership: 7395%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-12-10Lynne PowellSenior VP - CCOSell2,000.009.0118,020.000.00https://www.sec.gov/Archives/edgar/data/882796/000112760218036067/0001127602-18-036067-index.htm
2018-12-10Lynne PowellSenior VP - CCOSell2,000.009.1118,220.000.00https://www.sec.gov/Archives/edgar/data/882796/000112760218036067/0001127602-18-036067-index.htm
2019-01-14Lynne PowellSenior VP - CCOSell954.009.208,776.800.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002141/0001127602-19-002141-index.htm
2019-01-16Lynne PowellSenior VP - CCOSell3,046.009.2728,236.420.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002367/0001127602-19-002367-index.htm
2019-01-18Lynne PowellSenior VP - CCOSell2,000.009.4018,800.000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002527/0001127602-19-002527-index.htm
2019-01-25Lynne PowellSenior VP - CCOSell6,000.009.6057,600.000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm
2019-01-28Lynne PowellSenior VP - CCOSell4,000.009.8839,520.000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm
2019-01-28Lynne PowellSenior VP - CCOSell2,000.009.9119,820.000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm
2020-03-01THERESA HEGGIEDirectorBuy1,666.003.004,998.0010,092.00https://www.sec.gov/Archives/edgar/data/882796/000112760220009089/0001127602-20-009089-index.htm
2019-11-18Alane P BarnesSenior VP, Chief Legal OfficerBuy20,000.001.4529,000.00102,061.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033008/0001127602-19-033008-index.htm
2020-06-01THERESA HEGGIEDirectorBuy1,112.004.504,998.4411,204.00https://www.sec.gov/Archives/edgar/data/882796/000112760220018715/0001127602-20-018715-index.htm
2020-08-31THERESA HEGGIEDirectorBuy1,204.004.154,996.6012,408.00https://www.sec.gov/Archives/edgar/data/882796/000112760220024644/0001127602-20-024644-index.htm
2019-05-17THOMAS R II STAABSenior Vice President and CFOSell2,500.007.4518,625.00125,176.00https://www.sec.gov/Archives/edgar/data/882796/000112760219019143/0001127602-19-019143-index.htm
2019-05-16THOMAS R II STAABSenior Vice President and CFOSell7,250.007.7255,970.00127,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219019143/0001127602-19-019143-index.htm
2019-01-31Yarlagadda S BabuSenior VP - Drug DiscoveryBuy19,686.001.2023,623.20127,786.00https://www.sec.gov/Archives/edgar/data/882796/000112760219003737/0001127602-19-003737-index.htm
2019-01-28THOMAS R II STAABSenior Vice President and CFOSell5,000.009.8549,250.00128,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219003053/0001127602-19-003053-index.htm
2019-05-15THOMAS R II STAABSenior Vice President and CFOSell7,250.007.9257,420.00130,176.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018740/0001127602-19-018740-index.htm
2019-01-31Yarlagadda S BabuSenior VP - Drug DiscoveryBuy12,188.001.2014,625.60132,272.00https://www.sec.gov/Archives/edgar/data/882796/000112760219003737/0001127602-19-003737-index.htm
2019-04-04THOMAS R II STAABSenior Vice President and CFOSell7,500.008.8166,075.00132,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219014988/0001127602-19-014988-index.htm
2019-05-02THOMAS R II STAABSenior Vice President and CFOSell7,750.007.3056,575.00132,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219017457/0001127602-19-017457-index.htm
2019-05-06THOMAS R II STAABSenior Vice President and CFOSell9,000.007.7569,750.00132,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219017457/0001127602-19-017457-index.htm
2019-05-09THOMAS R II STAABSenior Vice President and CFOSell9,750.007.6374,392.50132,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018347/0001127602-19-018347-index.htm
2019-05-13THOMAS R II STAABSenior Vice President and CFOSell9,750.007.7675,660.00132,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018347/0001127602-19-018347-index.htm
2019-05-14THOMAS R II STAABSenior Vice President and CFOSell4,500.007.6234,290.00132,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018740/0001127602-19-018740-index.htm
2019-01-28THOMAS R II STAABSenior Vice President and CFOBuy5,000.005.4527,250.00133,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219003053/0001127602-19-003053-index.htm
2019-05-16THOMAS R II STAABSenior Vice President and CFOBuy4,750.001.426,745.00134,926.00https://www.sec.gov/Archives/edgar/data/882796/000112760219019143/0001127602-19-019143-index.htm
2019-05-14THOMAS R II STAABSenior Vice President and CFOBuy4,500.001.426,390.00137,176.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018740/0001127602-19-018740-index.htm
2019-05-15THOMAS R II STAABSenior Vice President and CFOBuy4,750.001.426,745.00137,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018740/0001127602-19-018740-index.htm
2019-04-04THOMAS R II STAABSenior Vice President and CFOBuy7,500.005.5141,325.00140,176.00https://www.sec.gov/Archives/edgar/data/882796/000112760219014988/0001127602-19-014988-index.htm
2019-05-02THOMAS R II STAABSenior Vice President and CFOBuy7,750.005.5142,702.50140,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219017457/0001127602-19-017457-index.htm
2019-05-06THOMAS R II STAABSenior Vice President and CFOBuy9,000.005.5149,590.00141,676.00https://www.sec.gov/Archives/edgar/data/882796/000112760219017457/0001127602-19-017457-index.htm
2019-05-09THOMAS R II STAABSenior Vice President and CFOBuy9,750.005.5153,722.50142,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018347/0001127602-19-018347-index.htm
2019-05-13THOMAS R II STAABSenior Vice President and CFOBuy9,750.005.5153,722.50142,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219018347/0001127602-19-018347-index.htm
2019-11-18KENNETH B JR LEEDirectorBuy5,000.001.457,250.0015,252.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033029/0001127602-19-033029-index.htm
2019-11-18Yarlagadda S BabuSenior VP - Drug DiscoveryBuy25,000.001.4536,250.00155,587.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033004/0001127602-19-033004-index.htm
2019-09-01THERESA HEGGIEDirectorBuy1,672.002.994,999.281,672.00https://www.sec.gov/Archives/edgar/data/882796/000112760219027871/0001127602-19-027871-index.htm
2018-12-10Lynne PowellSenior VP - CCOBuy2,000.003.226,440.002,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760218036067/0001127602-18-036067-index.htm
2019-01-18Lynne PowellSenior VP - CCOBuy2,000.003.226,440.002,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002527/0001127602-19-002527-index.htm
2019-01-28Lynne PowellSenior VP - CCOBuy2,000.003.226,440.002,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm
2019-03-12STEVE ASELAGEDirectorBuy2,000.008.3016,600.002,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219011361/0001127602-19-011361-index.htm
2019-11-18STEVE ASELAGEDirectorBuy15,000.001.4521,750.0021,672.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033001/0001127602-19-033001-index.htm
2019-12-01STEVE ASELAGEDirectorBuy1,754.002.854,998.9023,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219034168/0001127602-19-034168-index.htm
2020-03-01STEVE ASELAGEDirectorBuy1,666.003.004,998.0025,092.00https://www.sec.gov/Archives/edgar/data/882796/000112760220009094/0001127602-20-009094-index.htm
2020-06-01STEVE ASELAGEDirectorBuy1,112.004.504,998.4426,204.00https://www.sec.gov/Archives/edgar/data/882796/000112760220018719/0001127602-20-018719-index.htm
2018-12-18William P SheridanSenior VP - CMOSell20,488.007.58155,299.042,725.00https://www.sec.gov/Archives/edgar/data/882796/000112760218036977/0001127602-18-036977-index.htm
2019-09-01ROBERT ALEXANDER INGRAMDirectorBuy6,270.002.9918,747.3028,088.00https://www.sec.gov/Archives/edgar/data/882796/000112760219027858/0001127602-19-027858-index.htm
2020-08-31STEVE ASELAGEDirectorBuy2,409.004.159,997.3528,613.00https://www.sec.gov/Archives/edgar/data/882796/000112760220024642/0001127602-20-024642-index.htm
2019-01-16Lynne PowellSenior VP - CCOBuy3,046.003.229,808.123,046.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002367/0001127602-19-002367-index.htm
2019-01-28Lynne PowellSenior VP - CCOBuy4,000.003.2212,880.004,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm
2019-09-01Nancy J HutsonDirectorBuy3,344.002.999,998.5643,046.00https://www.sec.gov/Archives/edgar/data/882796/000112760219027862/0001127602-19-027862-index.htm
2019-11-18Megan SniecinskiChief Business OfficerBuy45,000.001.4565,250.0045,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033033/0001127602-19-033033-index.htm
2019-11-18ROBERT ALEXANDER INGRAMDirectorBuy20,000.001.4529,000.0048,088.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033025/0001127602-19-033025-index.htm
2019-05-22STEVE ASELAGEDirectorBuy3,000.003.5710,710.005,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219019891/0001127602-19-019891-index.htm
2019-11-18Nancy J HutsonDirectorBuy10,000.001.4514,500.0053,046.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033022/0001127602-19-033022-index.htm
2020-08-11Anthony DoyleChief Financial OfficerBuy54,000.004.08220,320.0054,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760220023449/0001127602-20-023449-index.htm
2019-12-01ROBERT ALEXANDER INGRAMDirectorBuy6,578.002.8518,747.3054,666.00https://www.sec.gov/Archives/edgar/data/882796/000112760219034162/0001127602-19-034162-index.htm
2019-12-01Nancy J HutsonDirectorBuy3,508.002.859,997.8056,554.00https://www.sec.gov/Archives/edgar/data/882796/000112760219034165/0001127602-19-034165-index.htm
2020-03-01Nancy J HutsonDirectorBuy3,333.003.009,999.0059,887.00https://www.sec.gov/Archives/edgar/data/882796/000112760220009065/0001127602-20-009065-index.htm
2019-01-25Lynne PowellSenior VP - CCOBuy6,000.003.2219,320.006,000.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm
2020-03-01ROBERT ALEXANDER INGRAMDirectorBuy6,250.003.0018,750.0060,916.00https://www.sec.gov/Archives/edgar/data/882796/000112760220009058/0001127602-20-009058-index.htm
2020-06-01Nancy J HutsonDirectorBuy2,224.004.509,996.8862,111.00https://www.sec.gov/Archives/edgar/data/882796/000112760220018711/0001127602-20-018711-index.htm
2020-08-31Nancy J HutsonDirectorBuy1,204.004.154,996.6063,315.00https://www.sec.gov/Archives/edgar/data/882796/000112760220024646/0001127602-20-024646-index.htm
2020-06-01ROBERT ALEXANDER INGRAMDirectorBuy4,171.004.5018,748.6565,087.00https://www.sec.gov/Archives/edgar/data/882796/000112760220018704/0001127602-20-018704-index.htm
2019-09-01STEVE ASELAGEDirectorBuy1,672.002.994,999.286,672.00https://www.sec.gov/Archives/edgar/data/882796/000112760219027867/0001127602-19-027867-index.htm
2019-11-18THERESA HEGGIEDirectorBuy5,000.001.457,250.006,672.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033017/0001127602-19-033017-index.htm
2020-08-31ROBERT ALEXANDER INGRAMDirectorBuy4,518.004.1518,749.7069,605.00https://www.sec.gov/Archives/edgar/data/882796/000112760220024637/0001127602-20-024637-index.htm
2019-11-18Jon P StonehousePresident & CEOBuy50,000.001.4572,500.00778,086.00https://www.sec.gov/Archives/edgar/data/882796/000112760219033035/0001127602-19-033035-index.htm
2019-12-01THERESA HEGGIEDirectorBuy1,754.002.854,998.908,426.00https://www.sec.gov/Archives/edgar/data/882796/000112760219034170/0001127602-19-034170-index.htm
2019-01-14Lynne PowellSenior VP - CCOBuy954.003.223,071.88954.00https://www.sec.gov/Archives/edgar/data/882796/000112760219002141/0001127602-19-002141-index.htm